Wednesday, April 17, 2024
HomeHealth LawDEA and SAMHSA Lengthen Tele-Prescribing Flexibilities

DEA and SAMHSA Lengthen Tele-Prescribing Flexibilities


This week, the Drug Enforcement Administration (“DEA”), together with the Substance Abuse and Psychological Well being Providers Administration (“SAMHSA”), issued a short-term rule extending the telemedicine waivers of the Ryan Haight Act (“RHA”) promulgated through the COVID-19 Public Well being Emergency (“PHE”). That is notable as entry to care, together with psychological well being and substance abuse therapy, stays a vital business focus, particularly because the transition to the post-PHE has begun.

The RHA usually requires a practitioner to carry out an in-person medical analysis previous to the prescribing of managed substances by way of telemedicine. The DEA waived this requirement for an in-person medical analysis through the PHE, so long as sure circumstances had been met. Underneath the short-term rule, all the telemedicine flexibilities relating to the prescription of managed substances that had been in place through the PHE will stay in place for a further six months (till November 11, 2023).

Moreover, if a affected person and a practitioner have established, or will set up, a telemedicine relationship on or earlier than November 11, 2023, all the telemedicine flexibilities relating to the prescribing of managed substances in place through the PHE will stay in place for a further 12 months (till November 11, 2024). A practitioner and a affected person have a “telemedicine relationship” if the practitioner has not carried out an in-person medical analysis of the affected person, and has prescribed a number of managed substances to the affected person pursuant to sure telemedicine flexibilities underneath the PHE waiver or the short-term rule.

As described in a earlier replace, the DEA proposed a rule in March 2023 to increase some flexibilities whereas making everlasting sure eventualities by which a practitioner might prescribe managed substances and not using a prior in-person analysis. After a file 34,000+ feedback had been acquired in response to the proposed rule, the DEA issued this short-term rule to advertise continued entry to care, guarantee a easy transition, and provides practitioners adequate time to come back into compliance with the necessities of the ultimate rule.

Practitioners ought to rigorously monitor for each federal and state regulation updates, as state regulation could impose completely different and doubtlessly extra stringent necessities. Our crew will proceed to trace developments and supply updates as they come up. Practitioners with questions or looking for counsel can contact any member of our Healthcare Workforce for help.

RELATED ARTICLES

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Most Popular

Recent Comments